Medicine
Aztreonam 2 g powder for injection
Aztreonam 2 g powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in original package at 20°C to 25°C (68°F to 77°F)., avoid excessive heat.
Key facts
- Active ingredient (INN)
- Aztreonam
- Brand
- Sold under the generic name
- Strength
- 2 g
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials and 1 more
- Manufacturers
- Fresenius KabiHospira
- Origin register
- US FDA, United States
- Storage
- Store in original package at 20°C to 25°C (68°F to 77°F)., avoid excessive heat.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DF01 Aztreonam
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 November 2009
- Identifiers
- RxCUI 1664981, 1664986DailyMed set ID d4500795-3b07-4a7d-b432-73cafbb3dbc6, 302fd27d-0a22-44ea-91fb-1b1ffcf17a1f, 5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18 +1NDC 0409-0830, 63323-402Application ANDA206517, ANDA065439
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 tray / 1 injection, powder, lyophilized, for solution in 1 vial | 63323-402-20 | Fresenius Kabi | 5 November 2009 |
| 10 vial in 1 tray / 1 injection, powder, lyophilized, for solution in 1 vial | 63323-402-24 | Fresenius Kabi | 5 November 2009 |
| 10 vial in 1 tray / 1 injection, powder, lyophilized, for solution in 1 vial | 63323-402-30 | Fresenius Kabi | 5 November 2009 |
| 10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose | 0409-0830-01 | Hospira | 24 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Aztreonam 2 g powder for injection.
Other strengths and forms of Aztreonam
Clinical summary
Aztreonam is a monobactam antibacterial indicated for the treatment of infections caused by susceptible Gram-negative microorganisms. It is available as powder for injection and kits for intramuscular and intravenous use. MedsAcross supplies Aztreonam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AztreonamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AZACTAM prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
- Cayston: European public assessment report (EPAR) · European Medicines Agency
Need Aztreonam 2 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.